Systematic review with meta‐analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation
Alimentary Pharmacology & Therapeutics2019Vol. 49(6), pp. 636–643
Citations Over TimeTop 10% of 2019 papers
Iris Steenstraten, Kerem Sebib Korkmaz, Palak Trivedi, Akin Inderson, Bart van Hoek, Mar D. M. Rodriguez Girondo, Jeroen Maljaars
Abstract
Multiple risk factors for rPSC were identified. Colectomy before liver transplantation reduced the risk of rPSC.
Related Papers
- → Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholangitis(2004)266 cited
- → Neutrophil Cytoplasmic Antibodies: A Link Between Primary Sclerosing Cholangitis and Ulcerative Colitis(1991)349 cited
- → High prevalence of small duct primary sclerosing cholangitis among patients with overlapping autoimmune hepatitis and primary sclerosing cholangitis(2008)79 cited
- → Neutrophil cytoplasmic antibodies: A link between primary sclerosing cholangitis and ulcerative colitis(1991)92 cited
- → Liver transplantation for primary sclerosing cholangitis(1999)15 cited